OPG/sRANKL ratio

Papers on OPG/sRANKL ratio

1 paper

Thursday, October 22

Journal of Cachexia, Sarcopenia and Muscle

Denosumab linked to greater grip strength gains in women

At 12 months, grip strength rose 1.45 kg with denosumab versus 0.66 kg with zoledronic acid in postmenopausal women with osteoporosis.At 12 months, grip strength rose 1.45 kg with denosumab versus 0.66 kg with zoledronic acid in postmenopausal women with osteoporosis.

Study design and multimodal assessment framework.
Cohort · 186 peopleDenosumab